| | |
| |  | Dear Startup Investor,
I'll keep this as brief as possible...
Because right now could be your last chance to get a head start on the projected $80 billion COVID-19 vaccine race.
I've been telling you to act quickly on three biotech stocks that could post up to 3,000% gains when all is said and done.
And I don't see the momentum stopping anytime soon - because NONE of these companies have even released clinical trial results yet.
But that all is expected to change...
By midnight on June 30, we're anticipating a game-changing announcement to hit.
This could send one of our vaccine picks into orbit.
That's why I'm giving you another chance at this...
And I STRONGLY suggest you watch this video now.
Because as we approach June 30, the opportunity is only getting BIGGER.
Click here to watch our presentation now.
Sincerely,
Bob Keppel
Publisher, The Startup Investor
| Please do not reply to this email. It was sent from an unmonitored mailbox.
You are receiving this e-mail at phanphuongthanh89.822152@blogger.com, as part of your subscription to The Startup Investor. To remove your email from this list: unsubscribe here.
To cancel, or for any other questions or requests, please contact our Customer Service team:
Online
Phone: 866-310-1498 (North America) 410-501-5876 (International)
Mail: The Startup Investor | Attn: Member Services | 1125 N Charles Street | Baltimore, MD 21201
Our Customer Service team is available Monday ‑ Friday between 9:00 AM and 5:00 PM ET.
© 2020 Angels & Entrepreneurs. All Rights Reserved.
Nothing in this email should be considered personalized financial advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized financial advice.
We expressly forbid our writers from having a financial interest in any security recommended to our readers. All of our employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of printed-only publication prior to following an initial recommendation. Any investments recommended in this letter should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company.
Protected by copyright laws of the United States and international treaties. This Newsletter may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of: Angels & Entrepreneurs. 1125 N Charles Street, Baltimore, MD 21201.
Website | Privacy Policy | Terms & Conditionshttp://link.e.angelsandentrepreneurs.com/wf/unsubscribe?upn=SVR9z3LgXEwEIVbUkFIuhfIKPV96lSE9UseWeXZ52MI4WY4eEn-2FXQBTN4MGeOz0GseIyndgO8daCHIwjmPi0EySCaAsypuV8RNEMBC-2FVlkhIHWMm1hw0uSXu4GkwGu9TAayNV8TQjBBSMH1t8f3YsH-2BEq2eiGipWZqe-2B8-2FM83BW0PLWRHvzNABv2mbfX6aOk5TH5SMZuuPW8hh6TAQZT9fEpDfepO-2BXQEpjalm4AVd9H8H79jtXtda0l0MFKGkgS7vNO0cI9lWVYoUq6MXjUF-2F7qfjYvbKyu1ZGcFyyTSLnjVwOLeq4zKbpGSkeE8QFokeavskF8iAMWDr0rdd4ETBj218mc3RI7r2wsPY94BYYb6xsQ8TUh5Ja-2F5kzCltP-2FBOYHp69dVb-2BLeCl5mPx-2BIv7FQT2JhyfD7FBVtilN-2Fz81jgCParSUl9QG5D1koP-2FRa2n9uk6UPtWtIVGbWT5RbapeLXQpUmGb4kEfkJNJOUD0cIrYhxHs8E3jt7QugrXcSQ0pGC-2FrUVLhE5gsi3o-2FU7sLVhAxHQsGdDpuBkG5J0Rdgi3Nbtkb2t27SJiDadD52kq9CYeZeIs2uTzjNvXOnPDTMvZsXfnKIhgTyWMlPrRsfUsvtFNZVPUO5lXAilFZgivtqXlldtAKPR3IFMwMZ2zEgwsq-2FifH1I7CLXazEoAPMWZVkuymWDStQFHxModkISStyHZUuPqw4643XqY4NVF9d3Cw0TiQ2XSEKWzLVzTLWd-2BPNbNklJfhSvBZ8Exaf3YAgeUROMrhT0jNLllKCLdTkp5EZfQqLqNE3WYbR7GtbJHtHdFW18r5Mdks8IcQIB-2Fbr0bxidYRCCc-2FdcVM8mRqwKxEuSutqu-2B-2BcKxY6xlnUpzDJd1FwIsYmCaGzBb2OVr95rIkzDXt48URQyX10-2Bftmjv3UjQqSyxlZJQitK7nwSG0a5Iiz883JeQe5kow90z1GMQtmieEUpoEj0HKHTek5GLr2-2FXEgbm6wl01RPk-3D |
|
No comments:
Post a Comment